Clinical Trials
6 trialsNCT06566209 2026-05-08
FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
Mayo Clinic
Terminated
NCT01920737 2025-09-16
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT06636175 2025-07-31
64Cu-LLP2A for Imaging Hematologic Malignancies
Washington University School of Medicine
Phase EARLY_PHASE1 Recruiting
NCT05255926 2025-06-26
CXCR4-targeted PET/CT Imaging in Hematological Malignancies
Zhongnan Hospital
Phase NA Recruiting
NCT03429387 2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA Completed
NCT03564704 2018-06-21
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown